13 July 2018 - US President Donald Trump bragged may have bragged about convincing Pfizer to hold off on price increases, but the pharmaceutical giant isn't the only drug company looking to charge more for its products.

In the first 10 days of July, at least 10 other drug makers and biotechnology companies raised prices on at least 20 brand-name medicines, a review of pricing data from Rx Savings Solutions and Bloomberg Intelligence shows.

The increases, for medications for cancer, diabetes, multiple sclerosis and liver disease, were generally each less than 10%, but the price of one little-prescribed sleep aid was raised by more than 700%.

Read Sydney Morning Herald article